Daniel Virnich - 12 Nov 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Executive Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Daniel Virnich
Issuer symbol
TOI
Transactions as of
12 Nov 2025
Net transactions value
$0
Form type
4
Filing time
14 Nov 2025, 16:30:04 UTC
Previous filing
22 May 2025
Next filing
19 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Virnich Daniel Chief Executive Officer C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS /s/ Mark Hueppelsheuser, Attorney-in-Fact for Daniel Virnich 14 Nov 2025 0001891107

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Award $0 +6,211 +0.35% $0.000000 1,793,520 12 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents RSU awards that were fully vested upon grant, net of withholding tax obligations.